
Loading, please wait...

Loading, please wait...

Surgeons often face significant challenges when performing Total Hip Arthroplasty (THA) for patients with Crowe type IV Developmental Dysplasia of the Hip (DDH). Specifically, the complete subluxation of the femoral head and a hypoplastic acetabulum complicate the procedure. To achieve safe reduction, surgeons frequently utilize femoral osteotomy techniques during Crowe IV DDH surgery. A recent retrospective study compares two prominent methods: low femoral neck osteotomy (LRNO) and subtrochanteric osteotomy (SO). Consequently, understanding these outcomes helps clinicians optimize perioperative care.
Researchers evaluated 73 patients undergoing cementless THA. While both techniques effectively manage the proximal femoral deformity, LRNO demonstrated several perioperative advantages. For instance, the LRNO group experienced significantly shorter operative times and smaller incision lengths. Moreover, patients in the LRNO group had lower blood loss and reduced transfusion requirements for both blood and plasma. These findings suggest that LRNO improves perioperative efficiency.
In addition to efficiency, clinical scores indicated a faster early recovery for LRNO patients. Specifically, the LRNO group achieved higher Harris Hip Scores (HHS) and Oxford Hip Scores (OHS) at one and three months postoperatively. However, this functional advantage leveled off by the six-month and 12-month marks. Ultimately, both groups showed comparable functional results at the one-year follow-up. Thus, while LRNO accelerates early recovery, the long-term functional benefits remain similar to subtrochanteric osteotomy.
Furthermore, radiographic analysis showed that LRNO resulted in a smaller postoperative leg length discrepancy (LLD). Clinically, this reduction in LLD contributes to improved patient satisfaction and gait. Regarding safety, the complication rates between the two groups did not differ significantly. This indicates that LRNO is as safe as the traditional subtrochanteric approach. Therefore, orthopedic surgeons may consider LRNO as a viable alternative to enhance early post-surgical outcomes.
Patients undergoing low femoral neck osteotomy (LRNO) typically experience faster functional recovery in the first three months compared to those having subtrochanteric osteotomy.
LRNO significantly reduces operative time, blood loss, and transfusion needs. However, the overall complication rate remains comparable to the subtrochanteric method.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study compares LRNO and SO in THA for Crowe IV DDH, showing LRNO provides faster recovery, less blood loss, and shorter operative times....
6 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today